Literature DB >> 15037529

Constitutive cardiac overexpression of sarcoplasmic/endoplasmic reticulum Ca2+-ATPase delays myocardial failure after myocardial infarction in rats at a cost of increased acute arrhythmias.

Ying Chen1, Brigitte Escoubet, Fabrice Prunier, Julien Amour, Warner S Simonides, Benoît Vivien, Christophe Lenoir, Michèle Heimburger, Christine Choqueux, Barnabas Gellen, Bruno Riou, Jean-Baptiste Michel, Wolfgang M Franz, Jean-Jacques Mercadier.   

Abstract

BACKGROUND: Heart failure often complicates myocardial infarction (MI), and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA2a) is underexpressed in the failing myocardium. We examined the effect of preexisting cardiac SERCA2a protein overexpression on rat survival and left ventricular (LV) remodeling after MI. METHODS AND
RESULTS: Baseline myocardial SERCA2a expression was 37% higher in transgenic (TG) rats than in their wild-type (WT) controls, consistent with enhanced myocardial function. The mortality rate of TG rats during the 24 hours after surgical MI was higher than that of WT rats (71% versus 35%, P<0.001), associated with a higher frequency of ventricular arrhythmias, and was normalized by lidocaine treatment. The increased acute-phase mortality in TG rats was not accompanied by increased 6-month mortality. Function of the noninfarcted myocardium, as assessed by tissue Doppler imaging, was higher in TG rats than in WT rats for up to 1 month after MI, a beneficial effect no longer observed at 3 months. LV remodeling and global function were similar in TG and WT rats. No difference in papillary muscle function was found at 6 months.
CONCLUSIONS: Constitutive cardiac SERCA2a overexpression has a transient beneficial effect on remote myocardium function in rat MI, with no improvement in LV global function or prevention of LV remodeling and failure. This benefit is associated with a higher risk of acute mortality, which is prevented by lidocaine treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15037529     DOI: 10.1161/01.CIR.0000124230.60028.42

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  34 in total

1.  Compromised myocardial energetics in hypertrophied mouse hearts diminish the beneficial effect of overexpressing SERCA2a.

Authors:  Ilka Pinz; Rong Tian; Darrell Belke; Eric Swanson; Wolfgang Dillmann; Joanne S Ingwall
Journal:  J Biol Chem       Date:  2011-01-29       Impact factor: 5.157

Review 2.  Regenerative therapies in electrophysiology and pacing: introducing the next steps.

Authors:  Gerard J J Boink; Michael R Rosen
Journal:  J Interv Card Electrophysiol       Date:  2010-12-16       Impact factor: 1.900

Review 3.  Remodeling of excitation-contraction coupling in the heart: inhibition of sarcoplasmic reticulum Ca(2+) leak as a novel therapeutic approach.

Authors:  Stefan Neef; Lars S Maier
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 4.  Prospects for gene transfer for clinical heart failure.

Authors:  T Tang; M H Gao; H Kirk Hammond
Journal:  Gene Ther       Date:  2012-04-26       Impact factor: 5.250

Review 5.  Gene therapy in heart failure.

Authors:  Leif Erik Vinge; Philip W Raake; Walter J Koch
Journal:  Circ Res       Date:  2008-06-20       Impact factor: 17.367

6.  Enhanced L-type calcium currents in cardiomyocytes from transgenic rats overexpressing SERCA2a.

Authors:  Andre Kamkin; Irina Kiseleva; Heinz Theres; Jaime-Jürgen Eulert-Grehn; Kay-Dietrich Wagner; Holger Scholz; Roland Vetter
Journal:  Exp Clin Cardiol       Date:  2010

Review 7.  Altered sarcoplasmic reticulum calcium cycling--targets for heart failure therapy.

Authors:  Changwon Kho; Ahyoung Lee; Roger J Hajjar
Journal:  Nat Rev Cardiol       Date:  2012-10-23       Impact factor: 32.419

Review 8.  Cellular mechanism of cardiac alternans: an unresolved chicken or egg problem.

Authors:  Yun-Liang Zang; Ling Xia
Journal:  J Zhejiang Univ Sci B       Date:  2014-03       Impact factor: 3.066

Review 9.  Heart failure management: the present and the future.

Authors:  Mohammad N Jameel; Jianyi Zhang
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

Review 10.  Sarcoplasmic reticulum Ca(2+) ATPase as a therapeutic target for heart failure.

Authors:  Larissa Lipskaia; Elie R Chemaly; Lahouaria Hadri; Anne-Marie Lompre; Roger J Hajjar
Journal:  Expert Opin Biol Ther       Date:  2010-01       Impact factor: 4.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.